Abstract
B cells bearing the CD5 surface marker comprise a substantial minority of the circulating lymphocyte population in healthy individuals. These recently described cells have been implicated in T-independent humoral responses, immunoregulation, and autoimmunity. We undertook to enumerate circulating CD5+ B cells by three-color fluorescence activated flow cytometry in 28 patients with Crohn's disease (CD). None of the CD patients were using immunosuppressive medication. The CD patients were subdivided into “inactive” and “active” groups based upon their Crohn's disease activity index (CDAI). Thirty-two normal subjects served as a control population. The percentage of CD19+ B cells was significantly reduced in both active and inactive CD patients as compared with normal controls (P≤0.01). CD5+ B cells were likewise found to be significantly decreased in both inactive and active CD patients (P≤0.01) as compared with normal controls. The proportion of CD5+ B cells was significantly lower in the peripheral blood of active as compared with inactive CD patients (P≤0.05). The finding that CD5+ B cells are reduced in CD may provide an important clue to immunological dysfunction in inflammatory bowel disease and merits further study.
Similar content being viewed by others
References
Hodgson HJF, Jewell DP: The humoral immune system in inflammatory bowel disease. II. Immunoglobulin levels. Am J Dig Dis 23: 123–128, 1978
Deodhar SD, Michener WM, Farmer RG: A study of the immunologic aspects of chronie ulcerative colitis and transmural colitis. Am J Clin Pathol 51: 591–597, 1969
Senju M, Hulstaert F, Lowder J, Jewell DP: Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease. Gut 32: 779–783, 1991
Eterman KP, Feltkamp TEW: Antibodies to gluten and reticulin in gastrointestinal diseases. Clin Exp Immunol 31: 92–99, 1978
Davidson IW, Lloyd RS, Whorwell PJ, Wright R: Antibodies to maize in patients with Crohn's disease, ulcerative colitis and celiac disease. Clin Exp Immunol 35: 147–148, 1979
Elson CO, Graeff AS, James SP, Strober W: Covert suppressor T cells in Crohn's disease. Gastroenterology 80: 1513–1521, 1980
Strickland RG, Friedler EM, Henderson CA, Wilson ID, Williams RD Jr: Serum lymphocytotoxins in inflammatory bowel disease. Studies of frequency and specificity for lymphocyte subpopulations. Clin Exp Immunol 21: 384–393, 1975
Brown DJC, Jewell DP: Cold-reactive lymphocytotoxins in Crohn's disease and ulcerative colitis. I. Incidence and characterization. Clin Exp Immunol 49: 67–74, 1982
Pfreundschuh M, Feurle GE, Springer A, Gause A, Beck JD: T-lymphocyte subpopulations in the peripheral blood of patients with Crohn's disease. Scand J Gastroenterol 16: 845–851, 1981
Yuan S-Z, Hanauer SB, Kluskens LF, Kraft SC: Circulating lymphocyte subpopulations in Crohn's disease. Gastroenterology 85: 1313–1318, 1983
Roche JK, Watkins MH, Cook SL: Inflammatory bowel disease: Prevalence and level of activation of circulating T-lymphocyte subpopulations mediating suppressor/cytotoxic and helper function as defined by monoclonal antibodies. Clin Immunol Immunopathol 25: 362–373, 1982
James SP, Neckers LM, Graeff AS, Cossman J, Balch CM, Strober W: Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease. Gastroenterology 86: 1510–1518, 1984
Raedler A, Fraenkel S, Klose G, Seyfarth K, Thiele HG: Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease. Gastroenterology 88: 978–983, 1985
Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Boirivant M: Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease.In vivo state of activation andin vitro response to stimulation as defined by the expression of early activation antigens. Gut 28: 745–753, 1987
Raedler A, Fraenkel S, Klose G, Thiele G: Elevated numbers of peripheral T cells in inflammatory bowel disease displaying T9 antigen and Fca receptors. Clin Exp Immunol 60: 518–524, 1985
Auer IO, Gotz S, Ziemer E, Malchow H, Ehms H: Immune status in Crohn's disease. 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, null and T lymphocytes. Gut 20: 261–268, 1979
Hardy RR, Hayakawa K: Development and physiology of Ly-1 B and its human homolog, Leu-1 B Immunol Rev 93: 53–79, 1986
Antin JH, Emerson SG, Martin P, Gadol N, Ault KA: Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J Immunol 136: 505–510, 1986
Gadol N, Ault KA: Phenotypic and functional charaterization of human Leu-1 (CD5) B cells. Immunol Rev 93: 23–34, 1986
Kipps TJ, Robbins BA, Carson DA: Uniform high frequency expression of autoantibody-associated crossreactive idiotypes in the primary B cell follicles of human fetal spleen. J Exp Med 171: 189–196, 1990
Caligaris-Cappio F, Janossy G: Surface markers in chronic lymphoid leukemias of B cell type. Semin Hematol 22: 1–12, 1985
Raveche ES: Possible immunoregulatory role for CD5+ B cells. Clin Immunol Immunopathol 56: 135–150, 1990
Paglieroni T, Caggiano V, MacKenzie M: CD5 positive immunoregulatory B cell subsets. Am J Hematol 28: 276–278, 1988
Casali P, Burastero SE, Nakamura M, Inghirami G, Notkins AL: Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science 236: 77–81, 1987
Becker H, Weber C, Storch S, Federlin K: Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity. Clin Immunol Immunopathol 56: 219–225, 1990
Smith HR, Olson RR: CD5+ B lymphocytes in systemic lupus erythematosis and rheumatoid arthritis. J Rheumatol 17: 833–835, 1990
Dauphinee M, Tovar Z, Talal N: B cells expressing CD5 are increased in Sjogren's syndrome. Arthritis Rheum 31: 642–647, 1988
Best WR, Becktel JM, Singleton JW, Kern F Jr: Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 77: 843–846, 1979
Senju M, Wu KC, Mahida YR, Jewell DP: Two-color immunofluorescence and flow cytometric analysis of lamina propria lymphocyte subsets in ulcerative colitis and Crohn's disease. Dig Dis Sci 36: 1453–1458, 1991
Author information
Authors and Affiliations
Additional information
Supported by a grant from the Canadian Foundation for Ileitis and Colitis.
Rights and permissions
About this article
Cite this article
Neil, G.A., Summers, R.W., Cheyne, B.A. et al. CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease. Digest Dis Sci 37, 1390–1395 (1992). https://doi.org/10.1007/BF01296009
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296009